1. Search Result
Search Result
Results for "

LRP5

" in MedChemExpress (MCE) Product Catalog:

6

Inhibitors & Agonists

1

Recombinant Proteins

1

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-125146

    Wnt Others
    BMD4503-2 is a quinoxaline derivative with inhibitory activity against LRP5/6-sclerostin interactions. BMD4503-2 restores the activity of the Wnt/β-catenin signaling pathway by competitively binding to the LRP5/6-sclerostin complex. BMD4503-2 can be used in the study of Wnt signaling pathways in bone development, maintenance and osteoporosis .
    BMD4503-2
  • HY-RS16292

    Small Interfering RNA (siRNA) Cancer

    Lrp5 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Lrp5 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Components

    Lrp5 siRNA-1: 5 nmol (HPLC)

    Lrp5 siRNA-2: 5 nmol (HPLC)

    Lrp5 siRNA-3: 5 nmol (HPLC)

    siRNA Negative Control: 5 nmol (HPLC)

    FAM-labeled siRNA Negative Control: 5 nmol (HPLC)

    GAPDH siRNA Positive Control: 5 nmol (HPLC)

    Lrp5 Mouse Pre-designed siRNA Set A
    Lrp5 Mouse Pre-designed siRNA Set A
  • HY-RS07800

    Small Interfering RNA (siRNA) Others

    LRP5 Human Pre-designed siRNA Set A contains three designed siRNAs for LRP5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    LRP5 Human Pre-designed siRNA Set A
    LRP5 Human Pre-designed siRNA Set A
  • HY-169508

    Wnt Others
    BMD4503-1 is a quinoxaline derivative. BMD4503-1 can inhibit the LRP5/6-Sclerostin interaction and regulate the Wnt signaling pathway .
    BMD4503-1
  • HY-E70390

    masp-2, c1 esterase, c1-esterase

    Wnt Cardiovascular Disease Inflammation/Immunology
    C1s Enzyme is a subunit of the complement C1 complex, which activates the complement as a serine protease. C1s Enzyme cleaves LRP5 and LRP6, and thus activates the Wnt/β-Catenin signaling pathway. C1s Enzyme promotes the macrophage M2 polarization and inhibits M1 polarization. C1s Enzyme enhances efferocytosis, exhibits anti-inflammatory activity .
    C1s Enzyme
  • HY-RS16291

    Small Interfering RNA (siRNA) Infection Cancer

    Bnip3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Bnip3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Components

    Bnip3 siRNA-1: 5 nmol (HPLC)

    Bnip3 siRNA-2: 5 nmol (HPLC)

    Lrp5 siRNA-3: 5 nmol (HPLC)

    siRNA Negative Control: 5 nmol (HPLC)

    FAM-labeled siRNA Negative Control: 5 nmol (HPLC)

    GAPDH siRNA Positive Control: 5 nmol (HPLC)

    Bnip3 Mouse Pre-designed siRNA Set A
    Bnip3 Mouse Pre-designed siRNA Set A

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: